---
title: Opioid-Free Intraoperative Anesthesia (OFIA) With ACB + IPACK
version: 1.2
last-updated: 2025-12-07
---

# Opioid-Free Intraoperative Anesthesia (OFIA) With ACB + IPACK

## 1. Purpose
Provide a standardized opioid-free intraoperative anesthesia (OFIA) protocol for robot-assisted total knee arthroplasty (rTKA) using adductor canal block (ACB) and IPACK nerve block to optimize analgesia, minimize opioid requirements, reduce PONV, and support ERAS ambulation goals.

---

## 2. Preoperative Phase

### Patient Assessment
- ASA classification, airway exam, METs, allergies
- Review opioid tolerance history
- Review PONV/delirium history
- Frailty/cognition assessment for elderly
- ASRA-compliant anticoagulation review:
  - **DOACs:** last dose ≥72 hours if CrCl > 50 mL/min  
  - **Warfarin:** INR ≤1.4  
  - **Prophylactic LMWH:** ≥12 hours  
  - **Therapeutic LMWH:** ≥24 hours  

### Medications (ERAS-aligned)
- **Acetaminophen 1 g PO** (give 30-60 min pre-op)
- **Celecoxib 400 mg PO** (give 1-2 hours pre-op; or meloxicam 15 mg if NSAID alternative needed)
- **Dexamethasone 8–10 mg IV** (give after IV placement)
- **Scopolamine 1.5 mg patch** (evening prior or ≥2 hrs pre-op for high PONV risk)
- **Avoid gabapentinoids** (ASA/APSF 2024)

### Regional Blocks (Ultrasound-Guided)

**Pre-Block Anxiolysis:**
- **Midazolam 1–2 mg IV** before block placement (anxiolysis + amnesia)

**Adductor Canal Block (ACB):**
- 20–30 mL ropivacaine **0.2–0.25%** (typical 25 mL)
- Ultrasound-guided, subsartorial approach (below sartorius muscle)
- Target: vastoadductor compartment
- Confirm negative aspiration before injection
- Incremental injection (5 mL aliquots)

**IPACK Block (Interspace between Popliteal Artery and Capsule of posterior Knee):**
- 20 mL ropivacaine **0.2–0.25%**
- Between popliteal artery and posterior capsule of knee
- Ultrasound-guided, popliteal fossa approach
- Confirm negative aspiration before injection
- Incremental injection

**Documentation:**
- Total ropivacaine dose (typically ~112.5 mg for 25 mL + 20 mL of 0.25%)
- Document dose is well below maximum (~3 mg/kg = 210 mg for 70 kg patient)
- Sensory coverage confirmed (quad-sparing, medial leg sensation)
- Motor function preserved (quadriceps strength intact)
- Patient comfort during procedure
- Block quality: excellent/good/fair/poor

---

## 3. Induction

**Pre-Oxygenation:**
- 100% FiO2 via tight-fitting mask for 3-5 minutes

**Induction Sequence:**
- **Midazolam 0.5–1 mg IV** (additional dose if needed; patient already received 1-2 mg for blocks)
- **Propofol 1.5–2 mg/kg IV** (universal induction agent)
- **Ketamine 0.3–0.5 mg/kg IV** (NMDA antagonism, analgesia)
- **Rocuronium 0.6–1.0 mg/kg IV** (neuromuscular blockade)

**Optional Loading Doses:**
- **Dexmedetomidine 0.5 mcg/kg IV over 10–20 minutes** (if using infusion; optional)
- **Magnesium sulfate 30–50 mg/kg IV over 15–20 minutes** (typical 40 mg/kg ≈ 3 g for 70 kg)

**Airway Management:**
- Endotracheal intubation or LMA per clinical judgment and surgical requirements
- Confirm ETCO2 waveform
- Secure airway device
- Document Cormack-Lehane grade if intubated

---

## 4. Maintenance

**Anesthetic Maintenance (Choose One):**
- **Sevoflurane 0.8–1.2 MAC** (preferred at UW for ease of titration)
  - OR
- **Propofol TIVA 75–150 mcg/kg/min** (preferred for high PONV risk or MH susceptibility)

**Adjunct Infusions:**
- **Dexmedetomidine 0.2–0.7 mcg/kg/hr** (lower range 0.2-0.4 for elderly/frail)
- **Ketamine 0.1–0.25 mg/kg/hr**

**Hemodynamic Management:**
- **Maintain MAP >65 mmHg**
  - **Phenylephrine 50-100 mcg IV** (preferred if HR >70)
  - **Ephedrine 5-10 mg IV** (preferred if HR <60)
- Monitor for dexmedetomidine-related bradycardia (HR <50)
  - Treat with **glycopyrrolate 0.2-0.4 mg IV** (preferred over atropine - longer duration, less tachycardia)

**Key Principle:**
- **No intraoperative opioids**

**Monitoring:**
- Standard ASA monitors (ECG, NIBP, SpO2, ETCO2, temperature)
- **Agent analyzer** for MAC/expired agent concentration (if using sevoflurane)
- Neuromuscular monitoring (TOF) if rocuronium used
- Consider BIS/depth monitoring (especially in elderly to minimize delirium risk)

---

## 5. Emergence

**10-15 Minutes Before End of Case:**
- Stop dexmedetomidine infusion (allow clearance before emergence)
- Continue ketamine infusion until skin closure complete

**At Skin Closure:**
- Stop ketamine infusion
- Reduce volatile agent (to 0.5-0.7 MAC) or propofol infusion gradually (reduce by 50%)

**Before Extubation:**
- **Ondansetron 4 mg IV** (PONV prophylaxis)
- **Sugammadex 2 mg/kg IV** if TOF shows residual blockade (TOF ratio <0.9 or <4 twitches)
  - OR **4 mg/kg IV** for deep block (1-2 post-tetanic counts)

**Extubation Criteria:**
- Awake, following commands, eyes open
- Adequate spontaneous ventilation:
  - Tidal volume >5 mL/kg
  - Respiratory rate 10-20 breaths/min
  - SpO2 >92% on room air or minimal supplemental O2
- TOF ratio >0.9 (or >4 twitches if qualitative monitor)
- Protective airway reflexes present (cough, gag)
- Hemodynamically stable

**Expected:**
- Smooth extubation due to OFIA regimen
- Minimal coughing/bucking
- Alert and oriented in PACU (typically within 10-15 minutes)

---

## 6. Postoperative Phase

### Expected PACU Pain Scores
- **NRS 0–3/10** typical with functioning blocks
- If NRS ≥4, assess for:
  - Incomplete block (patchy coverage)
  - Tourniquet pain (resolves quickly)
  - Surgical complication
  - Block failure (rare with ultrasound guidance)

### Scheduled Analgesia
- **Acetaminophen 1 g PO/IV q6h** (max 4 g/day)
- **NSAID of choice:**
  - Celecoxib 200 mg PO q12h, OR
  - Ketorolac 15 mg IV q6h (max 60 mg/day, limit to 48-72 hours; check renal function), OR
  - Meloxicam 15 mg PO daily
- **No routine opioids expected**

### Rescue Analgesia (Stepwise)
1. **First-line:** Ketamine 0.1–0.15 mg/kg IV q10–15 min PRN (for NRS ≥4)
   - Max 3 doses (total ~0.3-0.45 mg/kg cumulative)
   - Monitor for dysphoria (rare at rescue doses)
   - Reassess pain after each dose

2. **Second-line (if ketamine inadequate after 3 doses):**
   - Hydromorphone 0.2 mg IV q10-15 min PRN
   - Titrate carefully with reassessment after each dose
   - Use minimal effective total dose
   - Enhanced monitoring if elderly/frail/OSA

### Non-Pharmacologic Measures
- Ice application to surgical site
- Elevation of operative limb
- Reassurance and anxiety management

### Mobilization
- **Target:** Ambulation on POD 0 (typically 4-6 hours post-op)
- Physical therapy evaluation when:
  - Alert and oriented
  - Pain controlled (NRS ≤4)
  - No orthostatic hypotension
- Quad-sparing blocks enable early mobilization without fall risk

### Block Duration and Transition
- **ACB + IPACK duration:** Typically 12-18 hours
- **Transition planning:** Ensure oral multimodal regimen established before block offset
- **Anticipate increased analgesic needs** at 12-18 hours post-op
- Proactive pain management prevents escalation

---

## 7. Notes

### Clinical Advantages
- **First-line pathway** for ERAS rTKA
- **Lowest PONV** (<10% incidence vs 30-40% with opioids)
- **Best early ambulation** (motor-sparing blocks enable POD 0 mobilization)
- **Least delirium** (opioid-free approach, especially important in elderly)
- **Superior analgesia** (NRS 0-3 vs 3-6 without blocks)

### Ideal Patient Population
- **Opioid-naïve patients** (primary indication)
- **Elderly (>70 years)** - reduced delirium risk with OFIA
- **High PONV risk** (females, non-smokers, history of motion sickness/severe PONV)
- **OSA patients** (avoid opioid-related respiratory depression)
- **Patients desiring rapid recovery** and early discharge

### Key Principles
- **Midazolam provides anxiolysis** for block placement and does not compromise opioid-free principles
- **Propofol (1.5-2 mg/kg) is the universal induction agent** for all pathways at UW
- **Sevoflurane and propofol TIVA are equally valid** maintenance choices:
  - Choose sevoflurane for standard workflow (most common at UW)
  - Choose propofol TIVA for high PONV risk or MH susceptibility
- **Blocks last 12-18 hours** - transition to oral multimodal analgesia as they wear off
- **Postoperative opioid rescue available** when clinically indicated - does not constitute pathway failure
- **Lipid emulsion 20% immediately available** for LAST preparedness

### Contraindications to This Pathway
**Consider alternative pathway (OFIA block-free or conventional) if:**
- Patient refusal of blocks
- Anticoagulation outside ASRA 2024-2025 windows (DOAC <72h, LMWH <12h therapeutic or <6h prophylactic)
- Active infection/sepsis
- Allergy to amide local anesthetics
- OFIA contraindications (acute psychosis, severe uncontrolled HTN, high-degree AV block)

---

## References
See master reference file: [`../../07_References_Evidence_2024.md`](../../07_References_Evidence_2024.md)
